347 related articles for article (PubMed ID: 18489712)
1. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.
Demeule M; Currie JC; Bertrand Y; Ché C; Nguyen T; Régina A; Gabathuler R; Castaigne JP; Béliveau R
J Neurochem; 2008 Aug; 106(4):1534-44. PubMed ID: 18489712
[TBL] [Abstract][Full Text] [Related]
2. Identification and design of peptides as a new drug delivery system for the brain.
Demeule M; Régina A; Ché C; Poirier J; Nguyen T; Gabathuler R; Castaigne JP; Béliveau R
J Pharmacol Exp Ther; 2008 Mar; 324(3):1064-72. PubMed ID: 18156463
[TBL] [Abstract][Full Text] [Related]
3. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
5. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
7. Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM).
di Polidoro AC; Cafarchio A; Vecchione D; Donato P; De Nola F; Torino E
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235232
[TBL] [Abstract][Full Text] [Related]
8. Transport characteristics of a novel peptide platform for CNS therapeutics.
Bertrand Y; Currie JC; Demeule M; Régina A; Ché C; Abulrob A; Fatehi D; Sartelet H; Gabathuler R; Castaigne JP; Stanimirovic D; Béliveau R
J Cell Mol Med; 2010 Dec; 14(12):2827-39. PubMed ID: 19818094
[TBL] [Abstract][Full Text] [Related]
9. Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.
Bertrand Y; Currie JC; Poirier J; Demeule M; Abulrob A; Fatehi D; Stanimirovic D; Sartelet H; Castaigne JP; Béliveau R
Br J Cancer; 2011 Nov; 105(11):1697-707. PubMed ID: 22027709
[TBL] [Abstract][Full Text] [Related]
10. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
11. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
12. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
[TBL] [Abstract][Full Text] [Related]
13. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
[TBL] [Abstract][Full Text] [Related]
14. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.
Yamada K; Hashimoto T; Yabuki C; Nagae Y; Tachikawa M; Strickland DK; Liu Q; Bu G; Basak JM; Holtzman DM; Ohtsuki S; Terasaki T; Iwatsubo T
J Biol Chem; 2008 Dec; 283(50):34554-62. PubMed ID: 18940800
[TBL] [Abstract][Full Text] [Related]
15. Influence of the Drug Position on Bioactivity in Angiopep-2-Daunomycin Conjugates.
Pethő L; Oláh-Szabó R; Mező G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834514
[TBL] [Abstract][Full Text] [Related]
16. A novel LRP1-binding peptide L57 that crosses the blood brain barrier.
Sakamoto K; Shinohara T; Adachi Y; Asami T; Ohtaki T
Biochem Biophys Rep; 2017 Dec; 12():135-139. PubMed ID: 29090274
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
18. High transcytosis of melanotransferrin (P97) across the blood-brain barrier.
Demeule M; Poirier J; Jodoin J; Bertrand Y; Desrosiers RR; Dagenais C; Nguyen T; Lanthier J; Gabathuler R; Kennard M; Jefferies WA; Karkan D; Tsai S; Fenart L; Cecchelli R; Béliveau R
J Neurochem; 2002 Nov; 83(4):924-33. PubMed ID: 12421365
[TBL] [Abstract][Full Text] [Related]
19. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo.
Kafa H; Wang JT; Rubio N; Klippstein R; Costa PM; Hassan HA; Sosabowski JK; Bansal SS; Preston JE; Abbott NJ; Al-Jamal KT
J Control Release; 2016 Mar; 225():217-29. PubMed ID: 26809004
[TBL] [Abstract][Full Text] [Related]
20. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]